Introduction: Diabetic retinopathy is a leading cause of blindness in adults of working age.
INTRODUCTION
Diabetic retinopathy is a leading cause of blindness in the UK, accounting for 14.4% of blindness in adults of working age [1] . Poor glycemic control and hypertension are both well-known factors that increase the rate of progression of diabetic retinopathy. Consequently, it is therefore not surprising that in patients with significant retinopathy these factors are not sufficiently under control [2] [3] [4] . Indeed, one study found that 65% of patients requiring laser treatment for diabetic maculopathy had suboptimal blood pressure control [5] .
The 2010 Diabetes UK Task and Finish Group recommended that all patients with retinopathy requiring active management or complex monitoring should have their diabetes care provided by specialist teams [6] . However, data from the 2014/2015 UK National Diabetes
Audit suggest that only 4.4% of patients are under specialist care for their diabetes and that the majority of patients in the UK are under the care of their primary care physician only [referred to as a general practitioner (GP) in the UK] [7] .
In line with the aforementioned recommendations we referred patients managed at our eye center who were only under the care of their GP for their diabetes and found to have sight-threatening diabetic retinopathy (STDR) to a diabetologist as part of a pre-determined protocol involving assessment in a dedicated clinic by diabetic retinopathy specialists. The aim of the retrospective study reported here was to determine the benefit of physician input in these patients by identifying the interventions that were made and thus assess the modifiable risk factors for retinopathy progression at the point of referral.
METHODS
Patients referred from the eye department to the dedicated retinopathy clinic between May 2013
and August 2014 were identified using the hospital computer system. Patients with STDR whose diabetes management was under the care of their GP only were referred for specialist input as part of a pre-determined protocol that had been set up previously. The case notes of the patients were reviewed. Data from referrals and documentation from resultant clinic appointments were analyzed. Patient demographics were extracted and recorded alongside the patient's co-morbidities and level of retinopathy in each eye at the time of referral (Table 1) . The retinopathy was graded as background, preproliferative and proliferative, and a maculopathy graded as present if clinically significant macular edema was present [8] (Table 2) . Current medical management was also noted, including drugs prescribed to control lipids, blood pressure, and blood glucose (Table 3) .
Clinic letters were used to identify if changes had been made to the patient's diabetes management following referral. The patient's most recent body mass index (BMI) measurement, glycated hemoglobin (HbA1c), blood pressure, and lipid panel were noted. Case notes were re-reviewed 12 months after the initial presentation to the dedicated retinopathy clinic, and blood pressure, HbA1c, and any changes to management were recorded.
Data were compared to the National Institute for Health and Care Excellence (NICE) guidelines for each parameter [9] . The target HbA1c level was 6.5% (48 mmol/mol) in patients with type 2 (T2D) diabetes treated with Under UK guidelines the study was designated as service evaluation and formal ethical approval was not required.
RESULTS
From the total of 54 patients referred to the dedicated diabetic retinopathy clinic, 32 patients reported to the clinic for an initial consultation, and 22 patients never attended the clinic at all. Following the initial clinic visit one patient was discharged from further follow-up and three patients failed to attend any further appointments. At baseline, antihypertensive medication was more commonly prescribed for patients with T2D than for those with T1D [12/22 (55%) vs. 3/10 (30%), respectively]. Changes were made to the medical management of 24 of the 32 (75%) patients who attended the clinic (Table 4) . Of the 18 patients with macular edema who attended the clinic, ten (56%) had changes made to their hypertensive medication while only two (11%) had changes made to their glycemic therapy. In both of these latter patients, pioglitazone was stopped and replaced with either liraglutide or sitagliptin.
Changes related to blood pressure control were made in 16 (76%) of the 21 patients with pre-proliferative/proliferative (grade R2/R3, respectively) retinopathy. These changes consisted of ten patients being started on an angiotensin converting enzyme (ACE) inhibitor, two patients being started on a calcium channel blocker, and four patients being started on combined therapy with both an ACE inhibitor and a calcium channel blocker.
Lipid profile measurements from the 12-month follow-up appointment were unavailable. [18] .
A HbA1c level of [8.0% has been associated with STDR [19] . Numerous randomized control trials have shown that optimal long-term control of blood glucose reduces the risk of retinopathy.
The Diabetes Control and Complications Trial
(DCCT) and the UK Prospective Diabetes Study (UKPDS) both showed statistically highly significant reductions in the incidence and progression of retinopathy in patients who were randomized to tight blood glucose control [20] . Among the patients in our study, 84% had an HbA1c of [8% at their initial appointment at the diabetic retinopathy clinic, and changes were made immediately in 31% of these patients to hyperglycemic medication.
The use of pioglitazone has been associated with macular edema [21, 22] . Two patients in [23] . The UKPDS found that tight control of blood pressure led to a 34% reduction in the rate of progression of retinopathy; more specifically, this trial found that for each 10 mmHg decrease in systolic blood pressure there was a 13% reduction in the risk of retinopathy [3, 5] . The UKPDS also showed that in patients with T2D, systolic blood pressure was strongly linked to the incidence of diabetic retinopathy [24] . The
Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR) found diastolic blood pressure to be a significant indicator of progression of diabetic retinopathy in patients with younger onset T1D. The WESDR also found that in patients with T1D and T2D, elevated diastolic blood pressure was associated with a significantly increased 4-year risk of developing macular edema [25] [26] [27] .
In our study 72% patients had a blood pressure that surpassed the target of 130/80 mmHg at the initial clinic visit, and changes to blood pressure management were made in 57% (13/23) of these. A further three patients were referred for 24-h blood pressure monitoring.
These findings suggest that blood pressure, a very easily measured parameter, may be a strong determining factor in identifying patients who would benefit from referral to the diabetologist. One study has suggested that blood pressure should be measured in all patients at every diabetes clinic appointment with the ophthalmologist [5] . However, in another study blood pressure recordings at an eye clinic were found to be significantly higher than comparative diabetes clinic measurements, possibly secondary to the white-coat effect [28] . Clearly, the benefits of one-off blood pressure measurements at eye clinics is of debatable value, and home and ambulatory blood pressure monitoring can provide objective data regarding individual blood pressure control.
Hypertension worsens with the progression of diabetes [29] . In our study, after 12 months of follow-up, blood pressure improvements were less consistent than those for glycemic control (Table 5 ). Only one additional patient had a combined target blood pressure. Three patients had an increase in their diastolic blood pressure such that it was no longer possible to achieve the target. The reasons for this increase are likely multifactorial and include the possibility of white-coat hypertension. Of 28 patients, Failure to attend outpatient appointments is a particularly prevalent issue in the diabetic population and is associated with poorer outcomes [38, 39] . Of the 54 patients referred by our eye department to the diabetic retinopathy clinic, 22 failed to attend their initial clinic appointment. One study found that the presence of major diabetic complications was associated with improved clinic attendance [40] . Only three of the 32 patients who presented to the diabetic retinopathy for their initial appointment failed to attend their first follow up appointment after 
CONCLUSION
We 
